10 companies
AIM
AIM ImmunoTech Inc
aim immunotech inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the united states.
Florida
NYSEAMERICAN
ADMA
Adma Biologics Inc
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases.
New Jersey
NASDAQ
CRSP
CRISPR Therapeutics AG
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
Switzerland
NASDAQ
CGTX
Cognition Therapeutics Inc
cognition therapeutics inc.
Pennsylvania
NASDAQ
HALO
Halozyme Therapeutics Inc.
we are a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment.
California
NASDAQ
IOVA
Iovance Biotherapeutics Inc
iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr.
California
NASDAQ
MESO
Mesoblast Ltd
mesoblast; (asx: msb; nasdaq:meso) is a world leader in innovative cell-based medicines.
Australia
NASDAQ
MBOT
Microbot Medical Inc
microbot medical was founded with the vision of pioneering micro invasive surgery, transforming one of the biggest trends in healthcare - minimally invasive surgery (estimated to be close to $20b by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision.
Massachusetts
NASDAQ
PHXM
PHAXIAM Therapeutics S.A.
founded in 2004, erytech is a biopharmaceutical company developing innovative therapies to target unmet medical needs, particularly in the fields of cancer and orphan diseases.
France
NASDAQ
RGEN
Repligen Corp.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs.
Massachusetts
NASDAQ
- Prev
- 1
- Next